• HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus: Techni

  2026-05-20

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the need for reproducible, high-yield synthesis of fluorescently labeled RNA probes for research applications such as in situ hybridization and Northern blot hybridization. It should not be used for diagnostic or therapeutic purposes, and is optimized for workflows demanding sensitive and efficient RNA fluorescence detection.

• Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG

  2026-05-20

  This study uncovers how carcinogen-induced super-enhancer RNA (seRNA-NPCm) promotes metastasis in nasopharyngeal carcinoma (NPC) by activating the NPM1/c-Myc/NDRG1 regulatory axis. The findings provide mechanistic insight into enhancer RNA function in cancer progression and suggest new avenues for biomarker and therapeutic development.

• Aptamer-Based tiRNA Enables Reversible, Precise Gene Silenci

  2026-05-19

  The reference study introduces tiRNA, a novel gene silencing platform that uses an aptamer-reverse complement chimera to block translation without degrading RNA. This approach offers reversibility, high specificity, and safety, representing a significant advance over traditional RNA-targeting strategies and expanding the therapeutic potential for precision gene regulation.

• Kir2.1 Inhibition Reduces PASMC Proliferation in PH Models

  2026-05-19

  This study demonstrates that inhibition of the Kir2.1 potassium channel decreases pulmonary artery smooth muscle cell (PASMC) proliferation and migration, key processes in pulmonary vascular remodeling in pulmonary hypertension (PH). The findings establish a mechanistic link between Kir2.1 activity and activation of the TGF-β1/SMAD2/3 pathway, offering new insights for targeted cardiovascular ion channel research.

• ECL Chemiluminescent Substrate Detection Kit: Hypersensitive

  2026-05-18

  The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) empowers researchers to achieve low picogram sensitivity in immunoblotting workflows, extending detection windows and reducing background. Its robust performance on both nitrocellulose and PVDF membranes makes it an essential tool for Western blot chemiluminescent detection of scarce proteins in complex biological samples.

• BIIE 0246: Unveiling Y2R Antagonism in Neural-Cardiac Resear

  2026-05-18

  Explore the scientific depth of BIIE 0246, a potent neuropeptide Y Y2 receptor antagonist, and discover how its precision enables advanced neural-cardiac interaction studies. This article uniquely bridges mechanistic insights with practical assay strategies, setting a new standard beyond previous reviews.

• Renalase Drives Aldosterone Production via PMCA4b/cAMP Pathw

  2026-05-17

  This study uncovers a novel mechanism by which renalase stimulates aldosterone synthesis in adrenocortical cells through the PMCA4b/cAMP axis, independent of classical calcium signaling. The findings provide new insight into the regulation of aldosterone and highlight potential targets for treating pathological aldosterone excess.

• Hetero-Galactan from Sanghuangporus vaninii: Structure and H

  2026-05-16

  This study systematically characterizes a novel hetero-galactan (SVP3) isolated from Sanghuangporus vaninii and demonstrates its significant hypolipidemic effects in a mouse model. The research elucidates molecular mechanisms via TLR4/NF-κB pathway modulation and provides a foundation for further exploration of bioactive polysaccharides in metabolic disease intervention.

• BIIE 0246: Applied Workflows for Neuropeptide Y Y2 Receptor

  2026-05-15

  Leverage BIIE 0246 for precise NPY Y2 receptor inhibition in cutting-edge neuroscience and metabolic models. This guide delivers optimized protocols, troubleshooting tips, and translational insights—anchored in recent advances on the adipose-neural axis and arrhythmogenesis.

• Gemcitabine Workflow Optimization in Cancer Research Assays

  2026-05-15

  Gemcitabine’s dual function as a DNA synthesis inhibitor and apoptosis inducer uniquely positions it for high-impact cancer research, from checkpoint signaling to tumor metabolism. This guide translates recent mechanistic breakthroughs into actionable workflows, with troubleshooting and parameterization for robust, reproducible assays.

• Cell Senescence β-Galactosidase Staining Kit: Precision in S

  2026-05-14

  Unlock artifact-free, high-specificity detection of cellular senescence with the Cell Senescence β-Galactosidase Staining Kit. This kit’s optimized workflow supports robust, reproducible assays for drug screening and cell aging research, translating advanced biomarker science into daily lab practice.

• Staurosporine: Broad-Spectrum Kinase Inhibitor for Cancer Re

  2026-05-14

  Staurosporine is a potent, broad-spectrum serine/threonine protein kinase inhibitor used extensively in cancer research. Its high-affinity inhibition of PKC and multiple tyrosine kinases enables robust apoptosis induction and angiogenesis studies. APExBIO’s Staurosporine (A8192) is a validated standard for kinase pathway dissection and tumor biology models.

• Engineering T Cell Immunity in Immune-Cold Tumors: Dual-Targ

  2026-05-13

  He et al. (2025) introduce a tumor-specific plasmid vector expressing anti-CD3 and LIGHT to remodel T cell infiltration and activation within immune-cold solid tumors. Their dual-modulation strategy significantly improves response to immunotherapies, including checkpoint inhibitors and CAR-T cells, with minimal toxicity—offering a promising translational platform for resistant tumor types.

• Nanozyme Hydrogel Disrupts ROS-Ferroptosis Cycle for Disc Re

  2026-05-13

  This study presents a nanozyme-functionalized hydrogel that interrupts the cycle of oxidative stress, ferroptosis, and inflammation in degenerative intervertebral discs. By integrating a nucleus pulposus cell membrane-coated black phosphorus@cerium oxide nanozyme, the hydrogel provides durable antioxidant and anti-inflammatory effects, advancing the therapeutic landscape for intervertebral disc degeneration.

• GRE Combination Suppresses Melanogenesis via CREB/MITF Pathw

  2026-05-12

  This study demonstrates that a mixture of glabridin, resveratrol, and ellagic acid (GRE) effectively inhibits melanogenesis, oxidative stress, and inflammation in cellular models. The work advances mechanistic understanding by linking GRE's effects to downregulation of the CREB/MITF signaling axis, highlighting its translational potential for pigmentation regulation research.

11396 records 1/760 page Next 12345 下5页 Last page